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MitochondriaVoltage dependent anion channel (VDAC) of mitochondria plays a crucial role in apoptosis. Human VDAC-1,
reconstituted in planar lipid bilayer showed reduced conductance when treatedwith curcumin. Curcumin inter-
acts with residues in theα helical N-terminus of VDAC and in the channelwall, as revealed bymolecular docking,
followed by mutational analysis. N-terminus mimicking peptide showed conformational changes in circular
dichroism, upon curcumin treatment. We propose that the interaction of curcumin with amino acids in
N-terminus and in channel wall ﬁxes the α helix in closed conformation. This restricts its movement
which is required for the opening of the channel.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Voltage dependent anion channel (VDAC) is the most abundant
protein in the outer mitochondrial membrane [1–3]. It serves as a
primary conduit between cell cytoplasm and mitochondria, facilitating
the exchange of ions and important biomolecules like ATP, ADP,
pyruvate and succinate [4–6]. Recent crystal structure reveals that
the major structural components of VDAC include 19 β strands and
an N-terminal α helix. 19 β strands constitute the β barrel and the N-
terminal α helix resides within the pore [7]. VDAC assumes an open
conformation at lower membrane potentials and closed state at poten-
tials more than ±20 mV. Unlike other channels, VDAC rarely exhibits
fully closed, nonconductive state and thus the ‘closed state’ often refers
to sub-conductance state which is still permeable to small ions. Open
state is anion selective while closed state prefers cations [4,8]. Although
there are controversies, large number of evidences support that the
N-terminus participates in the gating of VDAC [8–12]. Flexibility
and strategic location of the α helix within the pore prompted the hy-
pothesis that channel opening is accompanied by the displacement ofel; HK, hexokinase; CD, circular
91 44 2257 4102.
y, Division of Structural Biologythe helix from its central position to the inner wall [13]. Alternatively,
outward movement of the α helix has also been proposed [14]. Teijido
et al. proposed the gating of VDAC without participation of N-terminal
α helix [15].
VDACplays amajor role inmitochondriamediated apoptosis [3,6,16,
17]. Several anti-apoptotic and pro-apoptotic proteins as well as
chemicals are known to target VDAC [18–20]. Intra-mitochondrial calci-
um overload mediated by VDAC, triggers the formation of permeability
transition pore (PTP). Increasedmitochondrial permeability is followed
by the release of cytochrome c to the cytosol which in turn activates the
death process [21,22]. Glycolytic enzyme hexokinase (HK), particularly
in cancer cells interacts with the N-terminus of VDAC and offers protec-
tion against apoptosis [23]. Disruption of VDAC-HK interaction en-
hances the sensitivity of cancer cells to chemotherapeutic agents [6].
Anti-apoptotic protein Bcl-xL directly interacts with VDAC [24]. Anti
VDAC-1 antibody prevented As2O3 induced cytochrome c release in iso-
lated mitochondria and Bax induced apoptosis in intact cells [25]. Simi-
larly, down regulation of VDAC-1 by siRNA prevented cisplatin induced
Bax activation and cell death [26].
Curcumin, a pigmented polyphenolic compound is known to have
anticancer activity [27]. It up-regulates pro-apoptotic proteins like Bax
and down regulates anti-apoptotic proteins, Bcl-2 and Bcl-xl [28]. The
down-regulation of anti-apoptotic proteins promotes the death process
by sensitizing cells to increase mitochondrial calcium, ROS generation,
cytochrome c release and activation of caspases [27–29]. Many ion
channels and transporters e.g. voltage gated potassium channels
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ABC transporters and glucose transporters are modulated by curcumin
[30] Curcumin-induced release of ‘apoptosis inducing factor’ (AIF)
involves VDAC [31]. Although curcumin is known to modulate various
proteins associated with cell survival and death, its direct effect on
VDAC has not been studied. We show that curcumin induces closure
of reconstituted hVDAC-1 in planar lipid bilayer. The key residues of
VDAC that interact with curcumin are identiﬁed and the possible
mechanism of VDAC-closure is discussed.
2. Materials and methods
2.1. Materials
Escherichia coliM15 (pREP4) bacterial strain and Ni-NTAmatrix were
purchased from Qiagen. Tris-Hcl, Guanidine HCl, Trition X-100 and DTT
(Dithiothreitol) were obtained from HiMedia, India. LDAO (N,N-
Dimethyldodecylamin-N-oxide) was purchased from Sigma Chemicals,
USA. Hydroxylapatite and celite were purchased from Bio-Rad, USA.
Curcumin was obtained from Loba Chime, India.
2.2. Expression and puriﬁcation of VDAC
Recombinant His-tag hVDAC-1 was expressed in E. coli M15
(pREP4). VDAC expression was induced with 1 mM IPTG. Harvested
cells were ruptured by sonication in the buffer containing 150 mM
NaCl, 30 mM Tris– HCl (pH 8). The lysate was centrifuged at 4800 ×g
for 30min at 4 °C. The pelletwaswashed in thebuffer containing 2% Tri-
ton X-100. The puriﬁed inclusion bodies were dispersed in buffer con-
taining 6 M Guanidine HCl, 10 mM DTT, 0.1 mM EDTA and 100 mM
Tris–HCl (pH 8). The extracted protein was re-folded in buffer contain-
ing 0.1 mM EDTA, 1 mM DTT, 100 mM Tris–HCl (pH 8) and 2% LDAO.Fig. 1. Characterization of puriﬁed hVDAC-1. A. SDS-PAGE proﬁle of puriﬁed hVDAC-1. 20 μg
Molecular weight of puriﬁed hVADC-1 appeared to be around 32 KDa. Lane 1, standard molecu
blot conﬁrming the puriﬁed protein as hVDAC-1. Lane 1, fraction after re-folding; Lane 2, puriﬁe
using a voltage ramp from−90mV to+90mV. Closing events are observed at higher voltages
versus voltage plot of hVDAC-1. Relative conductance decreased with increasing voltages, a typ
line represents ﬁtted curve, generated using Gaussian function (Sigma plot 11).The protein solution was centrifuged at 150,000 ×g for 45 min. The su-
pernatant was dialyzed twice against phosphate buffer (pH 6) contain-
ing 0.1% LDAO for 24 h.His-tag VDACwas puriﬁed usingNi-NTA column
as described before [32]. Bovine brain VDAC was puriﬁed using
hydroxylapatite-celite column as described before [33].
2.3. SDS-PAGE and Western blotting
Homogeneity of the puriﬁed VDAC was checked on SDS-PAGE. Puri-
ﬁed protein sample was resolved on 12% gel as per standard Lammeli's
method, followed by silver staining [34]. Molecular weight of the
puriﬁed hVDAC-1 was compared using standard molecular weight
marker (BioRad). For western blot, 20 μg of puriﬁed hVDAC-1 was re-
solved on SDS-PAGE. After electrophoresis, proteins were transferred
to polyvinylidene ﬂuoride (PVDF) membrane (Bio-Rad, USA), and
then blocked with 5% bovine serum albumin (BSA) and 0.1% Tween-
20 in Tris-buffered saline (TBS) for 1 h at room temperature (22 °C–
24 °C). The blot was incubated overnight at 4 °C with monoclonal anti-
body against hVDAC-1 (Cell Signaling Technologies, USA) at 1:750 dilu-
tion. After several washes with TBS-Tween-20 solution, the blot was
incubated for 1 h with HRP-conjugated secondary antibody (GeNei,
Lot No: 031062) at 1:5000 dilution. The blot was treatedwith super sig-
nalwest pico-chemiluminescent substrate (Thermo Scientiﬁc, USA) and
visualized on X-ray ﬁlm (Amersham, USA).
2.4. Site directed mutagenesis
The mutants of hVDAC-1: K15A, R18A, D19A and Y198F were creat-
ed using Quick Change mutagenesis kit (Stratagene, La Jolla, CA, USA)
according to themanufacturers' protocol. The primers used for generat-
ing themutants are shown in Supplementary Table 1. Themutationwas
conﬁrmed by sequencing.of puriﬁed protein was resolved on 12% polyacrylamide gel, followed by silver staining.
lar weight marker; Lane 2, Fraction after refolding; Lane 3, puriﬁed hVDAC-1. B. Western
d hVDAC-1. C. Representative current voltage (I-V) plot of hVDAC-1. I-V plotwas generated
. D. Relative conductance (G: conductance at a given voltage; G0: maximum conductance)
ical signature of VDAC. Values are the mean ± SEM of 10 independent observations. Solid
Fig. 2. Effect of Curcumin on VDAC-1. A. Representative current traces recorded at+10mV/−10mV and respective all point histograms (below the current traces) are presented. Current
value decreasedwhen 50 μMof curcuminwas added to the cis side. Left panel shows control hVDAC-1without curcumin. B. Current traces recorded from bovine brain VDAC. Dotted lines
in red represent base line (0 pA) and the holding potentials are indicated in the left.
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Fig. 3. Effect of curcumin on single channel conductance of hVDAC-1. Curcumin decreased
single channel conductance in all test voltages. Control data are shown in black and
curcumin treated data are in red. Values are the mean ± SEM of 15 independent
experiments.
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Puriﬁed VDAC was reconstituted in planer lipid bilayer as described
before [35]. Brieﬂy, the bilayer was formed with 1,2-diphytanoyl-
sn-glycero-3 phosphatidyl choline (DPhPC) (Avanti Polar Lipids,
Alabaster, AL), dissolved in n-decane (20 mg/ml). Lipid was painted
on the aperture (150 μm diameter) of polystyrene bilayer cuvette
(Warner Instrument, USA). Both cis and trans chambers contained
symmetrical solution of 1 M KCl, 5 mM MgCl2 and 10 mM HEPES
(pH 7.4). The cis chamber was held at virtual ground and the trans
chamber was connected to the recording ampliﬁer through PC501A
head-stage (Warner Instrument, USA). Ag-AgCl electrodes were
used. After formation of stable bilayer, puriﬁed VDAC was added to
the cis chamber and the solution was mixed with magnetic stirrer.
Channel insertion was monitored by observing membrane currents
at different voltages. Once the channel insertion was noticed, the
solution of cis chamber was replaced with fresh solution to limit
further insertion of channels. To check the effect of curcumin, it
was added to the cis chamber (50 μM ﬁnal concentration). Channel
activity was recorded at different voltages before and after the addi-
tion of curcumin. Currents were low pass ﬁltered at 1 kHz and digi-
tized at 5 kHz. The pClamp software (version 9, Molecular Devices)
was used for data acquisition and analysis.
2.6. Protein-ligand docking
Docking studies were performed to locate the probable binding site
of curcumin on VDAC. Docking analysis was carried out using Autodock
4.2 [36]. The structure of VDAC was obtained from Protein Data Bank
(PDB ID: 2JK4) [37] and the chemical structure of curcumin was
retrieved from PubChem data base (ID: 969516). A total of 100 binding
conformationswere generated by docking curcumin in the ﬂexible form
to VDAC crystal structure. Polar hydrogens were added to the protein
structure and Kollman united atom partial charges were assigned to
both protein and ligand. The grid box was taken sufﬁciently large at
90Å×90Å×90Å, keeping the protein at the center, to ensure unbiased
docking. Genetic Algorithm was used and the docked complexes were
scored based on binding free energy of the ligand to protein.
2.7. UV–visible spectroscopy
To evaluate the interaction of N-terminal fragment of VDAC
with curcumin, we measured the absorbance of curcumin in the
presence and absence of the peptide. The peptide, corresponding
to the N-terminal ﬁrst 21 amino acids of VDAC was synthesized
by M/S Genpro Biotech, New Delhi, India. For UV–visible spectros-
copy, the molar ratio of peptide and curcumin was kept 1:1 (50 μM
of each) and spectra were recorded in the range of 300–700 nmusing
JASCO spectrophotometer. The base line was corrected using respec-
tive buffer.
2.8. Circular dichroism (CD) spectroscopy
The peptide containing N-terminal ﬁrst 21 amino acids of hVDAC-1
was used for CD spectroscopy. CD spectroscopy of the peptide with
and without curcumin was performed in phosphate buffer saline
(PBS) as well as in methanol. 50 μM of peptide (dissolved in PBS) was
incubatedwith equimolar curcumin for 30min in dark at room temper-
ature. For CD spectroscopy, the peptide was dissolved in methanol and
treatedwith varying concentrations of curcumin (0–1 μM, inmethanol)
in dark for 10 min at room temperature [38]. For secondary structural
analysis, 200 μl of incubated sample was placed into a 0.1 cm path-
length quartz cell (Hellma, Forest Hills, NY) and the spectra were ac-
quired at 25 °C in far-UV range (198 nm–260 nm) with JASCO J-810
CD polarimeter. Three independent measurements were performed
with each sample. To calculate the secondary structural component,the CD data were deconvoluted using CDPro software package. This
software contains three algorithms (CONTINLL, SELCON3, and CDSSTR)
for determining the relative secondary structural components [39].
3. Results
3.1. Effect of curcumin on hVDAC-1
The purity of isolated protein was checked on SDS-PAGE, followed
by silver staining. As shown in Fig. 1A, VDAC-1 appeared as ~32 kDa sin-
gle bandon SDS-PAGE, conﬁrming its homogeneity. Further, to establish
the identity of hVDAC-1, western blot was performed with anti VDAC-1
antibody. Western blot showed prominent hVDAC-1 band (Fig. 1B). For
functional characterization, VDAC-1was reconstituted in planar lipid bi-
layer. Puriﬁed protein was added to the cis compartment (10 μg/ml,
ﬁnal concentration) and the channel insertion was monitored by mea-
suring membrane currents at different voltages. Current–voltage (I–V)
plot of VDAC-1 is shown in Fig. 1C. Channels show distinct closing
events at higher voltages. This is a well known property of hVDAC-1
[4,8]. Normalized conductance (G/G0) versus voltage plot of VDAC is
shown in Fig. 1D. In agreement with previous reports, relative conduc-
tance is highest at voltages around 0 mV and it decreased almost sym-
metrically with the increase of positive and negative voltages [4,8].
The effect of curcumin on reconstituted VDAC-1 was studied by
adding it to the cis chamber (50 μM,ﬁnal concentration). Representative
current traces recorded at +/−10 mV are shown in Fig. 2. Membrane
currents reduced signiﬁcantly after curcumin treatment, implicating
that curcumin induces channel closure. Equal volume of vehicle
(DMSO) alone had no effect on VDAC-1. Like the recombinant protein,
VDAC isolated from bovine brain mitochondria had also showed similar
effect (Fig. 2B). Fig. 3 depicts single channel conductance of VDAC-1
measured at different voltages before and after curcumin treatment.
Curcumin treated VDAC-1 showed reduced conductance at all voltages.
Single channel conductance (in 1 M KCl) at +10 mV was 4.5 ± 0.2 nS
which reduced to 1.8 ± 0.15 nS after curcumin treatment.
3.2. Molecular docking of curcumin on hVDAC-1
Wehave performed protein-ligand docking to understand themode
of curcumin binding and to locate the VDAC residues that might play
crucial roles in curcumin binding. Docking was performed by probing
the curcumin molecule all across the VDAC-1 surface and N-terminal
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curcumin were clustered based on their free energy of binding. Nearly
30% of the curcumin conformations were found to fall in the lowest
energy cluster, with an average energy of−7.5 kcal/mol (Supplemen-
tary Fig. S1). Detailed structural analysis on the representative confor-
mation from this cluster showed that curcumin preferentially binds
to the N-terminal α helix region with a bridging interaction to VDAC
wall. In this mode of binding, hydrogen bonding interactions with
N-terminal α helix residues K15 and R18 were involved. A stacking
interaction between Y198 and one of the phenyl rings of curcumin
was also found to play a crucial role in the binding (Fig. 4A). Further
analysis revealed the existence of multiple, relatively weaker hydro-
phobic interactions with VDAC N-terminal and wall residues. This is
shown in Fig. 4B. Based on these ﬁndings, we selected K15, R18, D19Fig. 4. A. The 3D representation of curcumin binding to hVDAC-1. hVDAC-1 is represented
in gray cartoon and curcumin is shown in cyan licorice. Interacting hVDAC-1 residues are
depicted in licorice representation in yellow. The electronegative oxygen and nitrogen
atoms in curcumin andprotein residues are shown in red and blue, respectively. Hydrogen
bonds between curcumin and VDAC residues are indicated by dotted lines. B. Interactions
of hVDAC-1 residueswith curcumin. The hydrogen bonding interactions of curcuminwith
VDAC residues K15 and R18 are shown by dotted lines. The other protein residues that
involve in hydrophobic interactions with curcumin are also indicated.
Fig. 5. A. Absorbance spectra of curcumin (50 μM) in the presence and absence of equimo-
lar concentration of peptide. An increase in curcumin absorbance intensity and a promi-
nent blue shift in its absorbance maxima were observed in the presence of peptide. B.
CD spectra of peptide (40 μM) with varying concentration of curcumin in methanol. As
evident in CD spectra, peptide adoptedα helical conformation inmethanol and curcumin
treatment increased its helical content.on N-terminus and Y198 on the channel wall for mutational studies
to assess their contribution in curcumin binding.3.3. Curcumin increases the helicity of synthetic peptide
The docking study identiﬁed multiple residues in N-terminus of
hVDAC-1 that may interact with curcumin. To study the interac-
tion, 50 μM of synthetic peptide, consisting of 21 amino acids of
N-terminus was incubated with equimolar concentration of
curcumin for 30 min at room temperature and the absorbance was
measured. In presence of the peptide, the curcumin spectrum
showed three-fold increase in absorbance with blue shift in the ab-
sorption maxima (Fig. 5A). The data clearly suggests that curcumin
interacts with the peptide. The same method had been used earlier
to demonstrate curcumin-protein interaction [40]. Further, we as-
sumed that synthetic peptide corresponding to the N-terminus,
might exhibit some conformational changes induced by curcumin.
However, the CD spectra of 50 μM peptide in PBS showed mostly
unstructured random coil conformation and its treatment with equi-
molar concentration of curcumin did not show any signiﬁcant struc-
tural changes (Supplementary Fig. S2). It suggests that though the
peptide has propensity for helix formation, it might need some
helix favoring conditions for adapting the helical conformation.
Therefore, we performed the CD experiment in methanol, which
favors helix formation in peptides. The data suggest that peptide ex-
hibited helix conformation in methanol, as evident by two minima
(at 222 nm and ~208 nm; Fig. 5B). CD spectra presented in Fig. 5B
revealed that helical content of peptide increased with increasing
concentrations of curcumin. The change in peptide helicity was
observed even at very low curcumin concentration (0.5 μM) inmeth-
anol. The helicity of the peptide alone was found to be 8.1% which in-
creased to 11.0%, 15.36% and 20.65% by 0.5 μM, 0.7 μM and 1.0 μM
curcumin respectively as calculated from CD Pro deconvolution
(Table 1). The CD spectroscopy measurements clearly suggest thatTable 1
Alteration of the secondary structure of N terminal peptide in the presence of curcumin.
Curcumin (μM) α-Helix (%) β sheet (%) Turn (%) Random coil (%)
0 8.1 31.06 14.26 41.56
0.5 11.03 30.83 16.93 37.0
0.7 15.36 28.83 17.9 35.76
1.0 20.65 34.43 15.5 43.4
The experiment was performed in methanol and the peptide concentration was kept
constant (40 μM).
Table 2
Effect of curcumin on single channel conductance ofwild type andmutant VDAC. Conduc-
tance was calculated at +80 mV in 1 M symmetric KCl solution. ⁎ P b 0.05, ⁎⁎ P b 0.01.
hVDAC-1 Single channel
conductance (nS) ± SEM
% reduction of conductance
after curcumin treatment
Wild type 2.09 ± 0.10 51
Wild type + curcumin 1.10 ± 0.04⁎⁎
K15A 1.85 ± 0.09 30
K15A + curcumin 1.30 ± 0.08⁎
R18A 2.08 ± 0.07 33
R18A + curcumin 1.39 ± 0.05⁎
D19N 1.91 ± 0.14 27
D19N + curcumin 1.38 ± 0.10⁎
Y198F 2.04 ± 0.12 39
Y198F + curcumin 1.25 ± 0.06⁎
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environment.3.4. Effect of curcumin on the mutant hVDAC-1
All the mutants of VDAC-1 i.e. K15A, R18A, D19N, Y198F except
K227A readily formed channel in planer lipid membrane. K227A didFig. 6. Effect of curcumin on different VDACmutants. VDACwas reconstituted in DPhPCmembr
resents base line (0 pA); applied voltages are written alongside. Application of curcumin induc
type (Table 2).not show any channel activity. Mutation did not cause any major
changes in the electrophysiological properties of VDAC, other than
slight decrease of single channel conductance for K15A and D19N. At
80 mV (in 1 M KCl), K15A showed single channel conductance of
1.85 nS compared to 2.09 nS for wild type (Table 2). The effect of
curcumin on different mutants of hVDAC-1 at−10 mV holding poten-
tial is shown in Fig. 6. Like wild type, curcumin induced the closure to
all mutants. However, when the effects of curcumin on single channel
conductance of mutants were compared, it appears that mutants are
less responsive to curcumin (Table 2). For example, at 80 mV (in 1 M
KCl) wild type hVDAC-1 showed a conductance of about 2.09 nS
which reduced by 51% upon curcumin treatment. On the other hand,
reduction of the conductance for mutants ranged between 28 and
39%, implying that mutation attenuated the effect of curcumin, but did
not abolish it completely. Similar effect of the curcumin was also
observed at lower holding potentials.4. Discussion and conclusion
The present study describes alteration of the gating of VDAC by
curcumin. Curcumin is a well-known pro-apoptotic agent and it has
been extensively studied in relation to its anti-cancer effect [27]. It hasane and channel activity was recorded in 1M symmetric KCl solution. Red dotted line rep-
es closure in all mutants; however the extent of inhibition is signiﬁcantly lower than wild
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transcription factors, different ion channels, transporters and wide
range of proteins involved in apoptosis pathway [27–30]. Although
VDAC plays a central role in mitochondria mediated apoptosis, its
modulation by curcumin has never been reported. Here we show that
curcumin directly interacts with hVDAC-1 and induces its closure.
hVDAC-1 reconstituted in planar lipid bilayer showed reduced conduc-
tance when treated with curcumin. Further, molecular docking identi-
ﬁed interacting residues, mostly in the N-terminal α helix and in the
inner wall of the channel forming β barrel. The synthetic peptide mim-
icking N-terminus showed interaction with curcumin as evident from
curcumin absorbancemeasurement study. Also, the helicity of this pep-
tide increasedwith increasing concentration of curcumin, as detected in
CD spectroscopy. Curcumin increased the helicity of the peptide, sug-
gesting its speciﬁc interaction. Based on the docking data,when the pre-
dicted interacting residues of N-terminus i.e. Lys15, Arg18 were
mutated to Ala andAsp19 to Asn, all the singlemutants of VDAC showed
reduced sensitivity to curcumin, suggesting their involvement in bind-
ing. As binding of curcumin involves multiple residues, it is expected
that single mutation would not abolish the effect completely. The
close proximity of docked curcumin to the Tyr198 of the inner wall es-
tablishes hydrophobic interaction whichwas reduced in Y198F mutant.
This mutant showed lesser sensitivity to curcumin.
N-terminal α helix of VDAC has been implicated in gating [4,8,9].
Although not universally accepted, it is generally believed that transi-
tion from closed to open state is accompanied by the conformational
movement of N-terminus. The crystal structure of VDAC reveals that
the N-terminal helix resides within the pore [7]. Apparently, the α
helix occludes the pore in the closed state and it is displaced towards
the inner wall of the channel leading to the opening. Therefore, interac-
tion of curcumin to the N-terminus at one end and to the Y198 at the
other end restricts the movement of α helix and thereby stabilizes the
closed state.
Whether stabilization of VDAC in closed state or in open state is
pro-apoptotic is controversial. Pro-apoptotic proteins e.g. Bax and Bak
have been reported to induce VDAC-opening. In the similar line, anti-
apoptotic Bcl-xL induced VDAC closure [41,42]. Interestingly, Bcl-xL
has also been shown to induce VDAC opening [43,44]. Optimum open-
ing of VDAC must be important for the exchange of ATP and ADP and
thus anti-apoptotic. VDAC prefers anion over cation in the open state.
Therefore, Ca2+ entry to the mitochondria, a pre-requisite for the
induction of mitochondrial permeability transition pore (MPTP) that
follows apoptosis, will also be limited in open state. Stabilization of
VDAC in the closed state presumably will induce apoptosis due to
disruption of normal metabolite ﬂux. This view is supported by the
fact that pro-apoptotic protein Bid induces VDAC closure [45]. It has
also been shown that in rat liver mitochondria, closure of VDAC
increased oxidative stress and accelerated Ca2+ mediated MPTP which
are considered as pro-apoptotic factors [46]. Therefore, VDAC-closure
by curcumin contributes to its well-known pro-apoptotic property.
Our study reveals a novel mode of action of curcumin.
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